Danielle M Nash
Overview
Explore the profile of Danielle M Nash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Clemens K, Ouedraogo A, Garg A, Silver S, Nash D
Kidney360
. 2022 Apr;
2(4):653-665.
PMID: 35373046
Background: Patients with diabetes receiving chronic, in-center hemodialysis face healthcare challenges. We examined the prevalence of gaps in their diabetes care, explored regional differences, and determined predictors of care gaps....
12.
Kalatharan V, Grewal G, Nash D, Welk B, Sarma S, Pei Y, et al.
Can J Kidney Health Dis
. 2022 Feb;
7:2054358120934628.
PMID: 35186303
Background: It is uncertain how often patients with autosomal dominant polycystic kidney disease (ADPKD) develop kidney stones. Objective: To review English-language studies reporting the incidence and prevalence of stones and...
13.
Howie A, Klar N, Nash D, Reid J, Zwarenstein M
BMC Fam Pract
. 2021 Dec;
22(1):243.
PMID: 34895165
Background: Printed educational materials (PEMs) have long been used to inform clinicians on evidence-based practices. However, the evidence for their effects on patient care and outcomes is unclear. In Ontario,...
14.
Molnar A, Bota S, Naylor K, Nash D, Smith G, Suri R, et al.
Nephrol Dial Transplant
. 2021 Dec;
37(12):2408-2417.
PMID: 34888696
Background: Chronic pain is common, and its management is complex in patients with chronic kidney disease (CKD), but limited data are available on opioid prescribing. We examined opioid prescribing for...
15.
Nash D, Bhimani Z, Rayner J, Zwarenstein M
BMC Fam Pract
. 2021 Jun;
22(1):126.
PMID: 34162336
Background: Learning health systems have been gaining traction over the past decade. The purpose of this study was to understand the spread of learning health systems in primary care, including...
16.
Robinson C, Jeyakumar N, Luo B, Wald R, Garg A, Nash D, et al.
J Am Soc Nephrol
. 2021 May;
32(8):2005-2019.
PMID: 34039667
Background: AKI is common during pediatric hospitalizations and associated with adverse short-term outcomes. However, long-term outcomes among survivors of pediatric AKI who received dialysis remain uncertain. Methods: To determine the...
17.
Kalatharan V, Welk B, Nash D, Dixon S, Slater J, Pei Y, et al.
Can J Kidney Health Dis
. 2021 Apr;
8:20543581211000227.
PMID: 33796322
Background: There is a perception that patients with autosomal dominant polycystic kidney disease (ADPKD) are more likely to develop kidney stones than the general population. Objective: To compare the rate...
18.
Kalatharan V, McArthur E, Nash D, Welk B, Sarma S, Garg A, et al.
Clin Kidney J
. 2021 Feb;
14(2):612-616.
PMID: 33623686
Background: The ability to identify patients with autosomal dominant polycystic kidney disease (ADPKD) and distinguish them from patients with similar conditions in healthcare administrative databases is uncertain. We aimed to...
19.
Harvey A, Burns K, McArthur E, Adhikari N, Li D, Kitchlu A, et al.
J Crit Care
. 2020 Dec;
62:76-81.
PMID: 33290929
Background: Sustained low efficiency dialysis (SLED) has emerged as an alternative to continuous renal replacement therapy (CRRT) for the treatment of acute kidney injury (AKI) in critically ill patients. However,...
20.
Kalatharan V, Welk B, Nash D, McArthur E, Slater J, Sarma S, et al.
Can J Kidney Health Dis
. 2020 Dec;
7:2054358120972830.
PMID: 33282326
Background: Ureteroscopy is a minimally invasive treatment option for upper tract stones. The distorted kidney anatomy in patients with autosomal dominant polycystic kidney disease (ADPKD) may place them at higher...